Product Information
RIVAROXABAN 1 MG/ML SUSPENSION is a generic product labeled by Ascend Laboratories, LLC, priced at $1.7482 per ML under NDC 67877088271. Its NADAC has been published 36 times since Dec 17, 2025.
FDA first approved this application on Jun 26, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Rivaroxaban market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
155 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877088271
Classification
Generic
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIVAROXABANApproval Type
Generic (ANDA)
FDA Application
ANDA218502FDA Approved
6/26/2025
TE Code
AB
On Market Since
7/7/2025
Pharmacological Classes
Price Statistics
The NADAC for RIVAROXABAN 1 MG/ML SUSPENSION has been published 36 times since Dec 17, 2025, and over the history we have for it it has declined 15.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7482 per ML |
|---|---|
| All-time high | $2.0669 (Feb 11, 2026) |
| All-time low | $1.7482 (Aug 19, 2026) |
| 52-week high | $2.0669 |
| 52-week low | $1.7482 |
| Median price | $1.9179 |
| Average price | $1.9199 |
| Largest weekly change | -4.0% (Apr 22, 2026) |
| Weeks tracked | 36 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Rivaroxaban market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIVAROXABAN 1 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 1 MG/ML SUSPENSION, manufactured by Ascend Laboratories, LLC, is $1.7482 per ML (NDC 67877088271), effective Aug 19, 2026.
How has the price of RIVAROXABAN 1 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for RIVAROXABAN 1 MG/ML SUSPENSION has declined 15.4%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for RIVAROXABAN 1 MG/ML SUSPENSION?
Since Dec 17, 2025, the NADAC for RIVAROXABAN 1 MG/ML SUSPENSION has ranged from a low of $1.7482 (Aug 19, 2026) to a high of $2.0669 (Feb 11, 2026), with a median of $1.9179 per ML.
Are there cheaper alternatives to RIVAROXABAN 1 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of RIVAROXABAN 1 MG/ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RIVAROXABAN 1 MG/ML SUSPENSION?
RIVAROXABAN 1 MG/ML SUSPENSION (NDC 67877088271) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.